Example: Heart Attack

Search clinical trials for: Alefacept

Total 41 results

NCT01319851

Terminated

Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation

Conditions: Thalassemia; Sickle Cell Disease; Glanzmann Thrombasthenia; Wiskott-Aldrich Syndrome; Chronic-granulomatous Disease; Severe Congenital Neutropenia; Leukocyte Adhesion Deficiency; Schwachman-Diamond Syndrome; Diamond-Blackfan Anemia; Fanconi Anemia; Dyskeratosis-congenita; Chediak-Higashi Syndrome; Severe Aplastic Anemia
NCT01226420

Terminated

Alefacept in Subjects With Steroid-Refractory Chronic Graft-versus-Host Disease

Conditions: Chronic Graft-versus-host Disease
NCT00655564

Completed

Long-Term One Year Use of Alefacept (Amevive®) in Moderate to Severe Chronic Plaque Type Psoriasis

Conditions: Psoriasis
NCT00953329

Terminated

Alefacept in Subjects With Chronic Plaque Psoriasis Who Failed to Respond to Anti-TNF Therapy

Conditions: Chronic Plaque Psoriasis
NCT01433770

Withdrawn

Alefacept in Kidney Transplant Recipients

Conditions: Kidney Transplantation
NCT01267643

Terminated

Alefacept in Patients With Relapsed/Refractory Aplastic Anemia

Conditions: Aplastic Anemia
NCT00795353

Terminated

Assess the Long-term Effectiveness and Safety of Amevive (Alefacept) in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Conditions: Chronic Plaque Psoriasis
NCT00653822

Completed

A Study of Pharmacokinetics and Safety of Alefacept in Caucasian and Japanese Healthy Volunteers

Conditions: Pharmacokinetics of Alefacept
NCT00454701

Terminated

Assessment and Tracking of Long-term Alefacept Safety

Conditions: Psoriasis
NCT00794807

Completed

Safety and Tolerability of Repeat Courses of IM Alefacept

Conditions: Chronic Plaque Psoriasis
NCT00832585

Completed

Study to Evaluate the Safety and Efficacy of Alefacept (Amevive) in Subjects With Moderate to Severe Atopic Dermatitis

Conditions: Atopic Dermatitis
NCT00808223

Completed

Safety and Pharmacokinetics (PK) of Alefacept in Adolescent Subjects With Moderate to Severe Psoriasis

Conditions: Psoriasis
NCT01163799

Terminated

A Pilot Study to Assess the Safety and Efficacy of Alefacept in de Novo Kidney Transplant Recipients

Conditions: Transplant; Failure, Kidney
NCT00965458

Terminated

Inducing Remission in Type 1 Diabetes With Alefacept

Conditions: New-onset Type 1 Diabetes Mellitus
NCT00815633

Terminated

A Pilot Study of Alefacept for the Treatment of Pityriasis Rubra Pilaris

Conditions: Pityriasis Rubra Pilaris
NCT00361413

Terminated

Alefacept for Prevention of Graft Versus Host Disease (GVHD)

Conditions: Graft Versus Host Disease
NCT00678470

Completed

Open Label Study of Alefacept Injections to Patients With Moderate to Severe Psoriasis

Conditions: Moderate to Severe Psoriasis
NCT00658606

Completed

Assess the Efficacy and Safety of Alefacept With Narrow Band Ultraviolet B Phototherapy (nbUVB) vs. Alefacept Alone in Chronic Plaque Psoriasis Subjects

Conditions: Plaque Psoriasis
NCT00342862

Terminated

AMEVIVE® Pregnancy Registry

Conditions: Pregnancy
NCT00438802

Completed

Alefacept in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma or Peripheral T-Cell Non-Hodgkin's Lymphoma

Conditions: Lymphoma
NCT00168753

Completed

Community Based Trial for AMEVIVE®

Conditions: Moderate to Severe Chronic Plaque Psoriasis
NCT00674063

Completed

A Study to Assess the Efficacy and Safety of Two Dosing Regimens of Alefacept in Subjects Weighing Between 100kg and 150kg With Moderate to Severe Chronic Plaque Psoriasis

Conditions: Chronic Plaque Psoriasis
NCT00617604

Completed

A Study to Assess the Efficacy and Safety of Alefacept in Kidney Transplant Recipients

Conditions: De Novo Kidney Transplantation
NCT00167102

Completed

Alefacept in Patients With Severe Scalp Alopecia Areata

Conditions: Alopecia Areata
NCT00692172

Completed

Open-label Study to Evaluate Safety of Multiple Courses of IM Alefacept During Treatment of Chronic Plaque Psoriasis

Conditions: Psoriasis